Lyell Immunopharma, Inc. (LYEL)

NASDAQ: LYEL · Real-Time Price · USD

25.50

+3.04 (13.54%)

At close: Mar 9, 2026, 4:00 PM EDT

26.20

+0.70 (2.75%)

After-hours: Mar 9, 2026, 7:53 PM EDT

Lyell Immunopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Mar '26 Mar 9, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	542	187	489	865	1,861	-	Upgrade
Market Cap Growth	180.94%	-61.73%	-43.52%	-53.52%	-	-	Upgrade
Enterprise Value	266	-215	-45	182	992	-	Upgrade
Last Close Price	25.50	12.80	38.80	69.40	154.80	-	Upgrade
PS Ratio	13212.70	3065.30	3758.66	10.22	174.77	-	Upgrade
PB Ratio	1.49	0.49	0.75	1.04	2.00	-	Upgrade
P/TBV Ratio	1.65	0.49	0.75	1.04	2.00	-	Upgrade
EV/Sales Ratio	6497.12	-	-	2.15	93.15	-	Upgrade
Debt / Equity Ratio	0.14	0.15	0.10	0.08	0.07	0.08	Upgrade
Net Debt / Equity Ratio	-0.84	-0.85	-0.76	-0.77	-0.89	-0.89	Upgrade
Net Debt / EBITDA Ratio	1.49	1.63	2.22	3.80	4.15	2.96	Upgrade
Net Debt / FCF Ratio	1.66	1.99	3.00	3.32	4.33	3.01	Upgrade
Asset Turnover	0	0	0	0.08	0.01	0.01	Upgrade
Quick Ratio	10.03	6.89	15.82	17.29	13.15	12.43	Upgrade
Current Ratio	10.30	7.06	16.07	17.59	13.40	12.53	Upgrade
Return on Equity (ROE)	-75.75%	-66.10%	-31.53%	-20.77%	-30.36%	-36.30%	Upgrade
Return on Assets (ROA)	-24.16%	-22.05%	-18.18%	-11.32%	-13.11%	-18.76%	Upgrade
Return on Capital Employed (ROCE)	-52.80%	-50.10%	-34.30%	-20.80%	-19.80%	-25.60%	Upgrade
Earnings Yield	-60.12%	-183.44%	-48.02%	-21.17%	-13.44%	-	Upgrade
FCF Yield	-30.56%	-87.10%	-34.05%	-22.40%	-10.30%	-	Upgrade
Buyback Yield / Dilution	-21.43%	-4.18%	-1.58%	-81.79%	-925.18%	-144.21%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.